Eric P. Winer MD

PubMed

• Racial and ethnic disparities in conversion to mastectomy following lumpectomy.
  Jasmine A Khubchandani, Madhav Kc, Pranam Dey, Ellie M Proussaloglou, Monica G Valero
  Breast Cancer Research and Treatment. 2025-05-01
• Prognostic and Predictive Insights From Genomic Assays for Breast Cancer in Diverse Populations: A Review.
  Yara Abdou, Olga Kantor, Jennifer Racz, Lisa Newman, Lori J Pierce
  JAMA Oncology. 2025-04-03
• 1 citations
  Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer.
  Otto Metzger Filho, Karla Ballman, Jordan Campbell, Minetta Liu, Jennifer Ligibel
  Journal of Clinical Oncology. 2025-04-01

Journal Articles

• Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer  
  Eric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
• Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer  
  Sara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
• Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 Study  
  M C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology
• Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer  
  Amreen Husain, Sylvia Adams, Hope S Rugo, Carlos H Barrios, Eric P Winer, The New England Journal of Medicine
• Join now to see all

Lectures

• Breast Cancer, New Horizons, Current Controversies 
  Harvard Medical School, Boston, Massachusetts - 7/11/2013
• 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS) 
  UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
• Breast Cancer, New Horizons, Current Controversies 
  Harvard Medical School, Boston, Massachusetts - 7/12/2012